Huawei Launches Sense G1: A Revolutionary Continuous Glucose Monitor
Huawei has officially introduced the Sense G1, marking its entry into the continuous glucose monitoring (CGM) market. This innovative arm-mounted sensor is designed to track glucose levels continuously throughout the day and night, providing users with timely alerts if their readings deviate from normal ranges. Data from the device can be easily accessed via a smartphone or smartwatch.
Key Features of the Huawei Sense G1
The Sense G1 features a compact, circular design reminiscent of an Apple AirTag. It is securely affixed to the arm, with a small needle gently penetrating the skin to gather readings from the interstitial fluid surrounding cells. Utilizing glucose oxidase and electrodes, the sensor measures glucose levels and translates them into corresponding blood sugar readings, eliminating the need for traditional finger-pricking methods.
This device is designed for individual use, requires no periodic calibration, and boasts a sensor lifespan of up to 16 days. According to reports, the Sense G1 exhibits a mean absolute relative difference (MARD) of less than 10%, indicating a strong correlation between its readings and standard laboratory measurements. However, users are advised that glucose readings may lag behind actual blood sugar levels by approximately 5 to 15 minutes.
Regulatory Approval and Development Journey
The Sense G1 has received approval from China’s National Medical Products Administration as a Class III medical device, the highest risk classification in the region. This approval places the device alongside critical medical products like cardiac stents and artificial joints, establishing its significance in the health technology landscape.
According to Li Xiaolong, CTO of Huawei Terminal BG, the development of the Sense G1 has been the most extended project the company has undertaken, with around 35 months dedicated to testing and refinement, beginning with a prototype worn by Li in December 2023.
Huawei has gradually advanced its health monitoring capabilities, launching the TruSense health monitoring system in 2024. While its smartwatches can assess diabetes risk, they lack the ability to directly measure glucose levels, a gap that the Sense G1 seeks to fill.
Availability and Future Prospects
As of now, Huawei has not disclosed the pricing or release date for the Sense G1. Further details may emerge during an upcoming event, at which the company is expected to unveil additional products, including the Huawei Mate X8 foldable smartphone and the MateBook Fold S laptop, which is anticipated to follow the original MateBook Fold Ultimate Design.
Discussion about this post